{
    "code": "06024125",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=06024125",
    "time": "2020-02-25 20:38:43",
    "許可證字號": "衛署醫器輸字第024125號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "QSD6740",
    "有效日期": "111\/11\/26",
    "發證日期": "101\/11\/26",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA00602412502",
    "中文品名": "玳而嵐 醣化血色素檢驗試劑組",
    "英文品名": "Diazyme Direct Enzymatic HbAlc Assay",
    "效能": "定量檢測人類全血中的醣化血色素。",
    "醫器規格": "DZ168A, DZ168A-CAL, DZ168A-CON,以下空白\r\n註銷規格：詳如中文仿單核定本。",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B7470糖(基)化血紅素分析",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "620118F253  瑞安國際股份有限公司",
    "申請商地址": "台北市信義區忠孝東路5段790巷17號5樓",
    "主製造廠": {
        "製造廠名稱": "MUS2921000  DIAZYME LABORATORIES",
        "製造廠廠址": "12889 GREGG COURT POWAY, CA 92064, USA",
        "製造廠公司地址": "",
        "製造廠國別": "UNITED STATES",
        "製程": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "06024125-106.10.17-106-10-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024125&Seq=002&Type=9"
        },
        {
            "title": "060241250002___20130125.pdf.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=06024125&Seq=001&Type=8"
        }
    ]
}